Issued Patents All Time
Showing 1–19 of 19 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 9346757 | Pyridine derivatives and their use in the treatment of conditions associated with pathological thrombus formation | Marc Nazare, Andreas Evers, Werngard Czechtizky | 2016-05-24 |
| 9346762 | Pyrazole derivatives and their use as LPAR5 antagonists | Marc Nazare, Andreas Evers, Werngard Czechtizky | 2016-05-24 |
| 9221784 | Benzo[1,3]dioxine derivatives and their use as LPAR5 antagonists | Marc Nazare, Martin Bossart, Werngard Czechtizky, Andreas Evers | 2015-12-29 |
| 8420321 | Method for the identification of a risk for a thrombogenic disorder by determining the TAFI-Ile347 polymorphism | Stefan Schaefer, Bernward Schoelkens, Karl-Ernst Siegler, Jean-Francois Deleuze, Sylvain Ricard +1 more | 2013-04-16 |
| 8329167 | EGLN2 variants and use thereof in preventing or treating thromboembolic disorders and coronary heart diseases | Matthias Herrmann | 2012-12-11 |
| 8211427 | EGLN2 variants and use thereof in preventing or treating thromboembolic disorders and coronary heart diseases | Matthias Herrmann | 2012-07-03 |
| 8198022 | Association of EDG5 polymorphism V286A with type II diabetes mellitus and venous thrombosis/pulmonary embolism and the use thereof | Evi Kostenis, Karl-Ernst Siegler, Martina Jacobs, Sylvain Ricard, Sandrine Mace +1 more | 2012-06-12 |
| 8114398 | EGLN2 variants and use thereof in preventing or treating thromboembolic disorders and coronary heart disease | Matthias Herrmann | 2012-02-14 |
| 8084198 | Use of a GIP promoter polymorphism | Matthias Herrmann, Karl-Ernst Siegler, Jean-Francois Deleuze, Sylvain Ricard, Sandrine Mace | 2011-12-27 |
| 8071297 | Method for the diagnosis and treatment of cardiovascular diseases | Matthias Herrmann, Thomas Leeuw, Wilfried Renner, Winfried Maerz | 2011-12-06 |
| 7985562 | Method for the identification of a risk for a thrombogenic disorder by determining the TAFI-lle347 polymorphism | Stefan Schaefer, Bernward Schoelkens, Karl-Ernst Siegler, Jean-Francois Deleuze, Sylvain Ricard +1 more | 2011-07-26 |
| 7892744 | Analysis and use of PAR1 polymorphisms for evaluating the risk of cardiovascular disorders | Joerg Czech, Karl-Ernst Siegler, Jean-Francois Deleuze, Sylvain Ricard, Sandrine Mace | 2011-02-22 |
| 7888020 | Association of EDG5 polymorphism V286A with type II diabetes mellitus and venous thrombosis/pulmonary embolism and the use thereof | Evi Kostenis, Karl-Ernst Siegler, Martina Jacobs, Sylvain Ricard, Sandrine Mace +1 more | 2011-02-15 |
| 7785781 | Method of diagnosis of a predisposition to develop thrombotic disease and its uses | Matthias Herrmann, Jean-Francois Deleuze, Sylvain Ricard, Sandrine Mace | 2010-08-31 |
| 7560290 | Method for the identification of a risk for a thrombogenic disorder by determining the TAFI-Ile347 polymorphism | Stefan Schaefer, Bernward Schoelkens, Karl-Ernst Siegler, Jean-Francois Deleuze, Sylvain Ricard +1 more | 2009-07-14 |
| 7262273 | Association of EDG5 polymorphism V286A with type II diabetes mellitus and venous thrombosis/pulmonary embolism and the use thereof | Evi Kostenis, Karl-Ernst Siegler, Martina Jacobs, Jean-Francois Deleuze, Sylvain Ricard +1 more | 2007-08-28 |
| 6645741 | Two-color differential display as a method for detecting regulated genes | Birgit Reuner | 2003-11-11 |
| 6602699 | Promotor for functional characterization of G-protein coupled receptors in the yeast saccharomyces cerevisiae | Almut Nitsche, Pauline Fraissignes, Sabine Gratzer, Ekkehard Leberer | 2003-08-05 |
| 6342376 | Two-color differential display as a method for detecting regulated genes | Birgit Reuner | 2002-01-29 |